Search Results - Alan Faraj
- Showing 1 - 3 results of 3
-
1
Phase III dose selection of marzeptacog alfa (activated) informed by population pharmacokinetic modeling: A novel hemostatic drug by Alan Faraj, Tom Knudsen, Shraddha Desai, Linda Neuman, Grant E. Blouse, Ulrika S. H. Simonsson
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Model‐informed pediatric dose selection of marzeptacog alfa (activated): An exposure matching strategy by Alan Faraj, Rob C. vanWijk, Linda Neuman, Shraddha Desai, Grant E. Blouse, Tom Knudsen, Ulrika S. H. Simonsson
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development by Laurynas Mockeliunas, Alan Faraj, Rob C. van Wijk, Caryn M. Upton, Gerben van den Hoogen, Andreas H. Diacon, Ulrika S. H. Simonsson
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book